newsfilter
← Latest News
Business Wire·

Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals

--Novvae to Focus Exclusively on OTC Product Candidates— --Clinical Trials for Virpax Rx Pipeline are Anticipated for 2024-- Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company